Lv7
3260 积分 2023-07-19 加入
Safety and Efficacy of Ianalumab in Patients With Sjögren's Disease: 52‐Week Results From a Randomized, Placebo‐Controlled, Phase 2b Dose‐Ranging Study
17天前
已完结
The evolving landscape of drug targets
18天前
已完结
Deep learning-assisted discovery of a potent and cell-active inhibitor of RNA N6-methyladenosine recognition protein YTHDC2
1个月前
已完结
Entering the agentic era of AI in drug discovery
1个月前
已完结
Contemporary design of small-molecule kinase modulators: orthosteric, allosteric and induced-proximity strategies
1个月前
已完结
The evolving landscape of obesity pharmacotherapy
1个月前
已完结
Safety considerations for cereblon-recruiting targeted protein degraders
1个月前
已完结
The evolving landscape of CDK inhibitor use in breast cancer therapy and beyond
1个月前
已完结
Roads and detours for CAR T cell therapy in autoimmune diseases
1个月前
已完结
Pharmacological targeting of the JAK–STAT pathway: new concepts and emerging indications
1个月前
已完结
皖公网安备34019202002308
